Source: International Congress 2018 – Paediatric asthma: new insights in its prevalence, treatment and treatment failure
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
s. ammari (Ariana, Tunisia), A. Berraies (Ariana, Tunisia), B. Hamdi (Ariana, Tunisia), E. Ben Jemia (Ariana, Tunisia), J. Ammar (Ariana, Tunisia), A. Hamzaoui (Ariana, Tunisia). Montelukast: neuropsychiatric adverse drug reactions in Tunisian asthmatic children. 4610

Member's Comments

No comment yet.

Related content which might interest you: Possible neuropsychic adverse reactions with montelukast in childhood asthma Source: Eur Respir J 2001; 18: Suppl. 33, 263s Year: 2001 Real-life long-term omalizumab therapy in children with severe allergic asthma Source: Eur Respir J 2015; 46: 856-859 Year: 2015 Severe adverse reactions in asthmatic children treated with specific immunotherapy(s.I.T.) Source: Eur Respir J 2003; 22: Suppl. 45, 318s Year: 2003 The effect of inhaled corticosteroids on symptoms in pre-school children with asthma-like symptoms in general practice: the ASTERISK study Source: Eur Respir J 2004; 24: Suppl. 48, 165s Year: 2004 Efficacy of cetirizine and pseudoephedrine in school children with seasonal allergic rhinitis and mild asthma Source: Eur Respir J 2002; 20: Suppl. 38, 526s Year: 2002 Systemic steroid use in children with allergic (IgE-mediated) asthma receiving omalizumab Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice Source: Eur Respir J, 50 (2) 1700148; 10.1183/13993003.00148-2017 Year: 2017 Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice Source: Eur Respir J, 50 (5) 1702135; 10.1183/13993003.02135-2017 Year: 2017 Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice Source: Eur Respir J, 50 (5) 1701984; 10.1183/13993003.01984-2017 Year: 2017 Omalizumab therapy reduces oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma: European real-life experience Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Safety of omalizumab therapy in children with allergic asthma Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Omalizumab in children with severe persistent allergic asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey Source: Eur Respir J 2013; 42: 1224-1233 Year: 2013 Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J 2014; 44: 332-340 Year: 2014 Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J 2015; 45: 565-566 Year: 2015 Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J 2015; 45: 566-567 Year: 2015 Efficacy of antiepileptic drugs diphenine and carbamazepine in pharmacotherapy of children with bronchial asthma: is asthma a neurogenic inflammatory disease? Source: Eur Respir J 2006; 28: Suppl. 50, 204s Year: 2006 Safety and efficacy of omalizumab in children with allergic asthma Source: Annual Congress 2011 - Treating childhood asthma Year: 2011 Is montelukast effective in allergic rhinitis in children? Source: Eur Respir J 2006; 28: Suppl. 50, 263s Year: 2006 Adherence to inhaled controller therapy and local adverse events in children with asthma Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009